Journal of Shandong University (Health Sciences) ›› 2025, Vol. 63 ›› Issue (1): 1-9.doi: 10.6040/j.issn.1671-7554.0.2025.0036

• Multidisciplinary Treatment and Clinical Innovation of Breast Cancer-Commentary •     Next Articles

Current status, challenges and innovative approaches of multidisciplinary treatment for breast cancer

YU Zhigang, ZHENG Chao   

  1. Breast Disease Diagnosis and Treatment Center, The Second Hospital of Shandong University, Jinan 250033, Shandong, China
  • Published:2025-02-20

PDF (PC)

145

Abstract: With the rising incidence of breast cancer, the multidisciplinary treatment(MDT)mode has become an important strategy for optimizing breast cancer diagnosis and treatment. This article analyzes the current status of breast cancer diagnosis and treatment in Shandong Province and comprehensively examines the implementation of MDT and the major challenges it faces, including the inadequacy of subspecialties, insufficient data sharing capabilities, uneven resource allocation, and the low enthusiasm of medical staff and patient participation. By summarizing Shandong Provinces experiences in the localized practice of the MDT mode, a series of innovative pathways suitable for national conditions are proposed, including standardizing treatment processes, building efficient information sharing platforms, strengthening patient follow-up and support systems, and deepening professional alliances and regional cooperation networks. Furthermore, by integrating the latest research in the fields of molecular biology, radiomics, and artificial intelligence in breast cancer, the prospects of multidisciplinary collaboration and modern technology in breast cancer diagnosis and treatment are explored, highlighting the role of digital healthcare transformation and precision medicine in promoting personalized treatment, aiming to provide theoretical support and practical references for breast cancer diagnosis and treatment in our country.

Key words: Breast cancer, Multidisciplinary treatment, Precision medicine, Information sharing platform, Digital healthcare

CLC Number: 

  • R737.9
[1] 山东省医学会乳腺疾病多学科联合委员会. 乳腺癌多学科协作诊疗山东共识(2024年版)[J]. 山东大学学报(医学版), 2025, 63(1): 10-16. Multidisciplinary Joint Committee on Breast Disease of Shandong Provincial Medical Association. Shandong Province expert consensus on multidisciplinary treatment of breast cancer(2024 edition)[J]. Journal of Shandong University(Health Sciences), 2025, 63(1): 10-16.
[2] Emerson MA, Reeder-Hayes KE, Tipaldos HJ, et al. Integrating biology and access to care in addressing breast cancer disparities: 25 years research experience in the Carolina Breast Cancer Study[J]. Curr Breast Cancer Rep, 2020, 12(3): 149-160.
[3] Blackwood O, Deb R. Multidisciplinary team approach in breast cancer care: benefits and challenges[J]. Indian J Pathol Microbiol, 2020, 63(Supplement): S105-S112.
[4] Hadžikadic'-Guc'iš L, Ceric' T, Marijanovic' I, et al. Guidelines for breast cancer management in Bosnia and Herzegovina[J]. Biomol Biomed, 2023, 23(1): 2-14.
[5] Meduri B, De Rose F, Cabula C, et al. Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study group[J]. Med Oncol, 2021, 38(6): 67. doi:10.1007/s12032-021-01514-w.
[6] Fabi A, Rossi A, Mocini E, et al. An integrated care approach to improve well-being in breast cancer patients[J]. Curr Oncol Rep, 2024, 26(4): 346-358.
[7] Rodríguez-Reinado C, Delgado-Parrilla A, Alguacil J. Breast cancer treatment in integrated care process in Andalusia: the challenge of multidisciplinarity[J]. Int J Environ Res Public Health, 2022, 19(19): 12728. doi:10.3390/ijerph191912728.
[8] Abdel-Razeq H, Mansour A. Challenges and opportunities in breast cancer care in low-resourced countries, Jordan as an example[J]. Cancers, 2024, 16(9): 1751. doi:10.3390/cancers16091751.
[9] 艾宪程, 王斐, 周文重, 等. 山东省38所三甲医院乳腺多学科诊疗现状[J]. 山东大学学报(医学版), 2025, 63(1): 108-114. AI Xiancheng, WANG Fei, ZHOU Wenzhong, et al. Current status of breast multidisciplinary team in 38 tertiary hospitals in Shandong Province, China[J]. Journal of Shandong University(Health Sciences), 2025, 63(1):108-114.
[10] Shinji O. Multidisciplinary care for patients with breast cancer[J]. Nihon Geka Gakkai Zasshi, 2017, 118(2): 173-178.
[11] Capobianco AL, Gallucci G, Lapadula L, et al. Impact of the multidisciplinary cancer team on the diagnostic and therapeutic care pathway of early breast cancer patients and perception of team members: the experience of a cancer centre in Italy[J]. Cancer Invest, 2024, 42(1): 12-20.
[12] Horlait M, Baes S, De Regge M, et al. Understanding the complexity, underlying processes, and influencing factors for optimal multidisciplinary teamwork in hospital-based cancer teams: a systematic integrative review[J]. Cancer Nurs, 2021, 44(6): 476-492.
[13] Puschel K, León A, Arancibia V, et al. The interdisciplinary and psychosocial gap in cancer survivorship: a longitudinal study in a Latin American Cancer Center[J]. J Surg Oncol, 2021, 124(5): 876-885.
[14] Cherny NI, Paluch-Shimon S, Berner-Wygoda Y. Palliative care: needs of advanced breast cancer patients[J]. Breast Cancer, 2018, 10: 231-243. doi:10.2147/BCTT.S160462.
[15] Aly SH, Abulsoud AI, Moustafa YM, et al. Harnessing natural compounds to modulate miRNAs in breast cancer therapy[J]. Funct Integr Genomics, 2024, 24: 211. doi: 10.1007/s10142-024-01489-7.
[16] Balcioglu O, Gates BL, Freeman DW, et al. Mcam stabilizes a luminal progenitor-like breast cancer cell state via Ck2 control and Src/Akt/Stat3 attenuation[J]. NPJ Breast Cancer, 2024, 10: 80. doi: 10.1038/s41523-024-00687-7.
[17] Sinha AP, Jurrius P, van Schelt AS, et al. Tumor biomechanics quantified using MR elastography to predict response to neoadjuvant chemotherapy in individuals with breast cancer[J]. Radiol Imaging Cancer, 2025, 7: e240138. doi: 10.1148/rycan.240138.
[18] Yu Y, Tan Y, Xie C, et al. Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer[J]. JAMA Network Open, 2020, 3: e2028086. doi: 10.1001/jamanetworkopen.2020.28086.
[19] Zhu JY, He HL, Lin ZM, et al. Ultrasound-based radiomics analysis for differentiating benign and malignant breast lesions: from static images to CEUS video analysis[J]. Front Oncol, 2022, 12: 951973. doi: 10.3389/fonc.2022.951973.
[20] Moser EC, Narayan G. Improving breast cancer care coordination and symptom management by using AI driven predictive toolkits[J]. Breast, 2020, 50: 25-29. doi:10.1016/j.breast.2019.12.006.
[21] Strach MC, Prasanna T, Kirova YM, et al. Optimise not compromise: the importance of a multidisciplinary breast cancer patient pathway in the era of oncoplastic and reconstructive surgery[J]. Crit Rev Oncol Hematol, 2019, 134: 10-21. doi:10.1016/j.critrevonc.2018.11.007.
[22] Wind A, Gonçalves FR, Marosi E, et al. Benchmarking cancer centers: from care pathways to integrated practice units[J]. J Natl Compr Canc Netw, 2018, 16(9): 1075-1083.
[23] Redjdal A, Bouaud J, Gligorov J, et al. Using machine learning and deep learning methods to predict the complexity of breast cancer cases[J]. Stud Health Technol Inform, 2022, 294: 78-82. doi:10.3233/SHTI220400.
[24] Vuksanovic D, Sanmugarajah J, Lunn D, et al. Unmet needs in breast cancer survivors are common, and multidisciplinary care is underutilised: the Survivorship Needs Assessment Project[J]. Breast Cancer, 2021, 28(2): 289-297.
[25] Monkkonen T, Traustadóttir Gá, Koledova Z. Unraveling the breast: advances in mammary biology and cancer methods[J]. J Mammary Gland Biol Neoplasia, 2020, 25(4): 233-236.
[26] Zhang X, Zhang D, Yu PD, et al. Effects of continuous care combined with evidence-based nursing on mental status and quality of life and self-care ability in patients with liver from breast cancer: a single-center randomized controlled study[J]. Comput Math Methods Med, 2022: 3637792. doi:10.1155/2022/3637792.
[27] Power K, Martone P, Khanna A, et al. The role of physiatry practice in a multidisciplinary breast tumor board: a descriptive study[J]. PM R, 2020, 12(5): 486-490.
[28] Cheng VT, Heetun A, Robinson T, et al. The breast cancer trainees research collaborative group: a new multidisciplinary network to facilitate breast cancer research[J]. Clin Oncol, 2020, 32(1): 16-18.
[29] 张舒妮,赵楠楠,李阳,等. 多模态影像组学列线图术前预测乳腺浸润性导管癌腋窝淋巴结转移的价值[J]. 磁共振成像, 2024, 15(4): 78-87. ZHANG Shuni, ZHAO Nannan, LI Yang, et al. Value of multimodal radiomics nomogram in predicting axillary lymph node metastasis in invasive ductal carcinoma of the breast before surgery[J]. Chin J Magn Reson Imaging, 2024, 15(4): 78-87.
[30] Verhoeven D, Allemani C, Kaufman C, et al. New frontiers for fairer breast cancer care in a globalized world[J]. Eur J Breast Health, 2021, 17(2): 86-94.
[1] GU Chunqing, GUO Ruisi, ZHOU Qinqin, LIU Henghui, BA Wanyu, SUN Shiling, WANG Bing, ZHENG Yuling, WU Suhui. Mechanism of Suanzaoren-Yuanzhi drug pair in the treatment of breast cancer related insomnia based on network pharmacology and animal experiments [J]. Journal of Shandong University (Health Sciences), 2026, 64(1): 99-108.
[2] LIU Baoguo, SONG Xiang, ZHAO Xiaowen, MAO Yali. Application value of serum STAT5B and NKAIN1 mRNA detection in breast cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(7): 68-74.
[3] WANG Xuemei, YANG Hao, SONG Yang, CHENG Shichao, ZHANG Tingting, WANG Yanchun. Causal association of antidiabetic drugs with female malignant tumours: a two-sample Mendelian randomisation study [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 67-77.
[4] . Shandong Province expert consensus on multidisciplinary treatment of breast cancer(2024 edition) [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 10-16.
[5] CHENG Yueqi, WANG Fei, YU Lixiang, ZHENG Chao, YU Zhigang. Progress in the study of trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 17-24.
[6] WANG Min, LI Xiping, TAN Jun, QIU Mei, HOU Zeyu, TIAN Ying, LUO Hongying, FAN Chaowen, QI Ling, YU Qi, XIE Wei. Lentivirus vector-mediated Gag-Caspase-8 induces apoptosis and S-phase arrest in triple-negative breast cancer primary cells [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 25-34.
[7] ZHANG Jie, ZHANG Fangfang, WANG Jingnan, LI Zeyu, SONG Ying, LI Na. Expression of circ_0000144 in breast cancer and its effect on the proliferation, migration and invasion ability of breast cancer cells [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 35-42.
[8] SONG Yawen, GUO Liantao, KONG Deguang, SUN Shengrong. VTCN1 causes poor prognosis and endocrine therapy resistance in HR+ breast cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 43-59.
[9] LIU Jingjing, PANG Jing, ZHAO Xiaodan, LIN Xin, FU Min, CHEN Jingjing. Machine learning model based on mammography and DCE-MRI to predict pathological complete response after neoadjuvant therapy in breast cancer: a dual center research [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 60-72.
[10] SUN Jing, YANG Ruimin, WANG Cong, ZHANG Yue, LUO Bing. Combined models based on preoperative ultrasound, inflammatory indicators and ultrasound radiomics for predicting axillary lymph node metastasis of breast cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 73-80.
[11] LI Yong, CUI Shujun, YANG Fei, ZHANG Fan, YIN Xiaoxia. Enhanced MRI-based subregional radiomics model can predict pathological complete response after neoadjuvant chemotherapy in breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 81-89.
[12] YUAN Zonghuai, PAN Guangye, CHI Yuemei, AN Chuanguo, ZHANG Yonggang. Causal relationship between low grade serous ovarian cancer and breast cancer analyzed by Mendelian randomization [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 99-107.
[13] AI Xiancheng, WANG Fei, ZHOU Wenzhong, YU Lixiang, ZHOU Fei, XIANG Yujuan, LI Liang, YU Zhigang. Current status of breast multidisciplinary treatment in 38 tertiary hospitals in Shandong Province, China [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 108-114.
[14] LIU Xiangrong, ZHANG Xinsheng, YANG Jinran, YANG Xueyan, LIU Zhao, LIU Yinghua. Association of the ratio of ω-6/ω-3 polyunsaturated fatty acids with various tumor types risk: a systematic review and Meta-analysis [J]. Journal of Shandong University (Health Sciences), 2024, 62(8): 34-48.
[15] ZHANG Nana, ZHAO Yiming, LIU Xinmin. Causal relationship between uterine leiomyomas and breast cancer: a two-sample Mendelian randomization study [J]. Journal of Shandong University (Health Sciences), 2023, 61(8): 86-93.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd